Skip to content

ELVNENLIVEN THERAPEUTICS INC

CUSIP 29337E102 · common stock

3 tracked investors held ENLIVEN THERAPEUTICS INC (ELVN) at the end of Q3 2026, worth $83M in total. The largest holder was Julian Baker, with 0.2% of its portfolio. Perceptive Advisors opened a new position this quarter.

Holders · Q3 2026
3
New holders
1
Value held
$83M
Quarter-end price (est.)
$45.84

Investors holding ELVN · Q3 2026

InvestorWeightSharesValueChange
Julian Baker
Baker Bros. Advisors LP
0.20%905,191$41.5MHOLD
Perceptive Advisors
Perceptive Advisors LLC
0.37%462,506$21.2MNEW
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.86%442,682$20.3MADD+14.2%

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Ron Baron0.00%7,500$380.6KEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026311$83M$45.84
Q2 2026310$66M$50.75
Q1 2026200$48.4M$39.20
Q4 2025200$4.6M$15.40